Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

26.53 -0.06 (-0.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
From STAAR Surgical Company
Via Business Wire
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
From Yunqi Capital Limited
Via Business Wire
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon
Via Stocktwits
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
From Broadwood Partners, L.P.
Via Business Wire
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
From STAAR Surgical Company
Via Business Wire
Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors
From Broadwood Partners, L.P.
Via Business Wire
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction
From Yunqi Capital Limited
Via Business Wire
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025
From STAAR Surgical Company
Via Business Wire
3 Unprofitable Stocks We Approach with Caution
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
From STAAR Surgical Company
Via Business Wire
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
From Broadwood Partners, L.P.
Via Business Wire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
From STAAR Surgical Company
Via Business Wire
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company
Defender Capital, which owns 1.5% of STAAR’s common stock, highlighted STAAR’s board of directors' rejection of Alcon's previous offer of $58 per share in cash. 
Via Stocktwits
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
From Yunqi Capital Limited
Via Business Wire
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
From STAAR Surgical Company
Via Business Wire
3 Unpopular Stocks We Think Twice About
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
From Alcon Inc. Investors and STAAR Surgical Company
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
From STAAR Surgical Company
Via Business Wire
3 Reasons to Avoid STAA and 1 Stock to Buy Instead
STAAR Surgical has been on fire lately. In the past six months alone, the company’s stock price has rocketed 52.2%, reaching $26.75 per share. This was partly thanks to its solid quarterly results, and... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.